These results could be explained by our in vitro experiments, where hepsin increased thrombin generation promoted by CRC cells, probably because of its capacity to activate coagulation factor VII (Halabian et al., 2009; Khandekar and Jagadeeswaran, 2014). The gene discussed is HPN; the disease is colorectal carcinoma.